4th International Conference on Cancer and Breast Cancer Treatment

Cancer is not a single disease but a collection of related diseases that can occur in nearly any part of the body. This session will introduce participants to the most common types of cancer, including lung cancer, breast cancer, prostate cancer, colorectal cancer, and skin cancer. Understanding how these cancers develop, their risk factors, and available treatments is crucial for both prevention and early detection. The session will explore how genetics, environment, and lifestyle influence cancer types and how to reduce risks.

Session Overview:

This session will cover the various types of cancer, their causes, and how they differ in terms of risk factors and treatment. Participants will gain a deeper understanding of the most common cancers, such as lung, breast, and prostate cancer, as well as less common types. Early detection and prevention strategies will also be discussed.

The COVID-19 pandemic has had a profound impact on cancer care, from delays in diagnosis and screenings to disruptions in treatment protocols. Cancer patients have faced challenges accessing timely care, and many elective procedures and treatments were postponed. The session will discuss the long-term effects of these delays on patient outcomes, the psychological toll on cancer patients, and the shift to telemedicine.

Session Overview:

This session will explore how the COVID-19 pandemic has affected cancer diagnosis, treatment, and patient outcomes. Participants will learn about delays in screenings, treatment disruptions, and the broader impact on cancer care during the pandemic. The session will also highlight strategies to mitigate these effects and improve cancer care moving forward.

This session will cover the critical processes of cancer screening and diagnosis, focusing on their importance in early detection and improving patient outcomes. Attendees will gain insights into common screening methods, diagnostic techniques, and the role of emerging technologies in transforming cancer detection. Early diagnosis is key to better prognosis, and this session will help healthcare professionals understand how timely intervention leads to more effective treatment and higher survival rates.

Session Overview:

This session will cover the essential aspects of Cancer Screening and Diagnosis, explaining how both are crucial for early detection and treatment of cancer. Attendees will learn about various methods for screening, the latest diagnostic technologies, and how early detection can significantly improve survival rates and outcomes for patients.

This session will focus on the molecular and genetic mechanisms driving cancer, including genetic mutations, epigenetic changes, and alterations in cellular signaling pathways. It will cover how these factors influence tumor progression and how we can leverage genomic insights to develop personalized treatment approaches.

Session Overview:

The session will delve into the core principles of cancer biology and genetics, exploring how mutations in oncogenes, tumor suppressor genes, and epigenetic changes contribute to cancer. Insights into these processes will help develop targeted therapies, enhance early detection methods, and offer new treatment strategies for various cancer types.

This session covers the different therapies available for cancer treatment, including surgery, radiation, chemotherapy, and advanced therapies like immunotherapy, targeted therapy, and stem cell transplants. Each method is explained in detail to help patients understand how it works and how it contributes to cancer management and recovery.

Session Overview:

This session explains various therapies used in the treatment of cancer. It covers traditional methods like surgery and chemotherapy, as well as advanced approaches like immunotherapy, targeted therapy, and stem cell transplants. The session will provide insight into how these therapies work and their role in managing cancer effectively.

This session will focus on the vital role of oncology nurses in the care of cancer patients, emphasizing their impact in managing treatment, symptoms, and patient well-being. Oncology nurses provide crucial support across all stages of cancer-from diagnosis through treatment to survivorship-ensuring comprehensive, compassionate care. The session will cover the latest advancements in oncology nursing practices, the importance of patient education, and the integration of personalized medicine into nursing care.

Session Overview:

In this session, we will explore the evolving role of oncology nurses in cancer care, highlighting their responsibilities in treatment administration, symptom management, and emotional support. We will discuss how oncology nurses collaborate with multidisciplinary teams to improve patient outcomes and enhance quality of life.

This session focuses on the essential signaling networks that regulate cellular growth, survival, and communication. It highlights how disruptions in major pathways-including MAPK, PI3K/AKT, JAK/STAT, and Wnt-contribute to cancer initiation, progression, and therapy resistance. Presentations will explore emerging research, biomarkers, and targeted therapeutic strategies aimed at improving precision oncology and enhancing patient outcomes.

• Oncogenic Activation of the PI3K/AKT/mTOR Cascade
• Dysregulation of the RAS/MAPK/ERK Pathway
• Cell Cycle Checkpoint Bypass and CDKs
• Mechanisms of Apoptosis Evasion (BCL-2 Family)
• Metabolic Reprogramming (The Warburg Effect)
• Signal Transduction Cross-talk and Bypass Resistance
• Targeting Kinases and Allosteric Inhibitors

This session will cover the primary treatment options for breast cancer, including surgery, chemotherapy, radiation therapy, and targeted therapies. We will discuss how these treatments are applied based on cancer stages and individual patient needs.

Session Overview:

Treatment for breast cancer often involves a combination of surgery, radiation, and systemic therapies like chemotherapy and targeted drugs. Each treatment plan is personalized based on the type and stage of cancer.

This session will explore HER2-positive breast cancer, a subtype of breast cancer that overexpresses the HER2 protein. We will discuss the diagnostic process, treatment options, and how therapies like targeted treatments and immunotherapies are revolutionizing the care of HER2-positive patients.

Session Overview:

HER2-positive breast cancer is an aggressive form, but it has become more treatable due to targeted therapies. This session covers the diagnosis, treatment options, and emerging therapies for HER2-positive breast cancer.

This session will provide an overview of the different surgical approaches used to treat breast cancer, including lumpectomy, mastectomy, and lymph node removal. The discussion will focus on the advantages and challenges of each procedure, and how the choice of surgery depends on the stage and type of breast cancer.

Session Overview:

Breast Cancer Surgery  plays a pivotal role in cancer treatment. This session explores surgical options, from breast-conserving surgeries to mastectomies, and addresses recovery, potential complications, and decisions based on cancer staging.

This session explores how radiology aids in cancer treatment by diagnosing, staging, monitoring treatment response, and detecting recurrences. Imaging techniques like CT scans, MRIs, and PET scans provide detailed insights into tumors, helping oncologists develop personalized treatment plans and improve patient outcomes through accurate and timely assessments.

Session Overview:

This session covers the role of radiology and oncology, focusing on how imaging techniques are used for diagnosing, staging, and monitoring cancer. We will explore various radiological tools, such as CT scans, MRI, and PET scans, and their impact on treatment planning and outcome assessment. The session aims to highlight how radiology aids in precise cancer care.

This session explores key oncology nursing and patient care models that strengthen the cancer care continuum. It highlights how nurses assess symptoms, manage treatment toxicities, provide emotional support, and coordinate multidisciplinary care. Emphasizing patient navigation, evidence-based practice, tele-oncology tools, survivorship care, and quality-improvement strategies, the session showcases the vital role of oncology nurses in enhancing treatment outcomes, ensuring safety, and improving overall quality of life.

• Patient-Centered Care Model
• Evidence-Based Nursing Practice
• Multidisciplinary Care Coordination
• Palliative and Supportive Care Model
• Survivorship Care Model
• Technology-Enhanced Nursing Care

This essential session advocates for the early integration of Palliative and Supportive Care throughout the cancer journey. It focuses on expert symptom management, improving quality of life, effective patient-provider communication, and providing comprehensive psycho-social support for both patients and their caregivers.

• Rationale for Early Integration in the Cancer Trajectory
• Advanced Management of Cancer-Related Pain (CRCP)
• Assessment and Treatment of Cancer-Related Fatigue (CRF)
• Effective Management of Gastrointestinal Symptoms
• Communication Skills for Prognosis and Goals of Care
• Addressing Psychosocial, Spiritual, and Financial Distress
• Caregiver Burden and Support Strategies

Session Overview 

This session highlights the evolving role of immunotherapy in breast cancer, focusing especially on triple-negative breast cancer (TNBC). Once considered immunologically "cold," breast tumors are now being targeted with immune checkpoint inhibitors, cancer vaccines, and emerging cellular therapies. Experts will explore key clinical trials, patient selection biomarkers, and combination strategies with chemotherapy or targeted therapy. The discussion will help clinicians apply current findings to practice and prepare for upcoming innovations in immunotherapy to improve patient outcomes.

Session Explanation 

Breast cancer immunotherapy has entered a new era, led by the success of checkpoint inhibitors in TNBC. This session delves into pivotal studies like IMpassion130 and KEYNOTE-355 and investigates immune evasion, tumor microenvironment modulation, and resistance mechanisms. Attendees will learn how to incorporate PD-L1 testing, manage immunotherapy-related toxicities, and evaluate ongoing trials of novel agents including vaccines and CAR-T cells. The session provides clinical and research perspectives on using immunotherapy in both metastatic and early-stage disease settings.

Session Overview 

This session explores how liquid biopsies are revolutionizing early cancer detection through non-invasive, real-time analysis of circulating biomarkers. By detecting circulating tumor DNA (ctDNA), circulating tumor cells (CTCs), and other cancer-related molecules in the blood, liquid biopsies offer a promising alternative to traditional tissue biopsies. Attendees will learn about the latest technologies, clinical trials, and FDA-approved tests, as well as future applications in cancer screening, treatment monitoring, and minimal residual disease detection across various cancer types.

Session Explanation 

Liquid biopsy technologies have emerged as powerful tools for early cancer detection, enabling clinicians to diagnose malignancies with a simple blood draw. This session will focus on key breakthroughs, including ctDNA detection, methylation-based assays, and multi-cancer early detection (MCED) platforms like GRAIL’s Galleri test. The role of liquid biopsies in screening high-risk populations and guiding adjuvant therapy decisions will also be emphasized, supported by current evidence and ongoing studies.

Session Overview

This session will explore the growing role of robotic-assisted techniques in breast cancer surgery, particularly in nipple-sparing mastectomy, axillary dissection, and reconstructive procedures. Robotic systems enhance precision, reduce scarring, and promote faster recovery. The session will also cover training challenges, cost-effectiveness, and the future integration of robotics into standard breast cancer treatment protocols.

Session Explanation

Robotic-assisted surgery has emerged as a minimally invasive alternative in breast cancer procedures, offering improved visualization and dexterity. Surgeons can operate through small incisions with enhanced control, potentially reducing complications and improving cosmetic outcomes. This session highlights real-world clinical data, including robotic nipple-sparing mastectomy and lymph node dissection, particularly in early-stage and prophylactic settings.

This session addresses the most aggressive breast cancer subtype lacking standard receptors. It covers new insights into TNBC heterogeneity, the role of immune checkpoint inhibitors, and chemotherapy-free strategies leveraging DNA repair deficiencies to improve outcomes in early and metastatic settings.

• Molecular Heterogeneity
• Integrating Immune Checkpoint Inhibitors
• Exploiting DNA Repair Deficiencies with PARP Inhibitors
• Role of Antibody-Drug Conjugates (ADCs) (e.g., Sacituzumab Govitecan)
• Optimizing Chemotherapy Regimens and Dose-Dense Strategies
• Management of Residual Disease After Neoadjuvant Therapy
• Addressing Brain Metastases in TNBC

Genomics and cancer biomarkers play an essential role in understanding tumor behavior, predicting patient outcomes, and guiding targeted therapies. This session explores how genetic mutations, molecular signatures, and biomarker panels are transforming cancer detection, personalized treatment planning, and therapy monitoring. Attendees will gain insights into cutting-edge research that links genomics with precision oncology, enabling earlier diagnosis and more accurate therapeutic decision-making.

Session Overview 

This session provides an in-depth look at the rapidly evolving field of cancer genomics and biomarkers. Experts will discuss advances in molecular profiling, next-generation sequencing, and biomarker-driven treatment strategies. The overview highlights the growing clinical relevance of genomic testing, companion diagnostics, and predictive markers in improving treatment response and long-term patient outcomes across various cancer types.

This session explores the integration of Artificial Intelligence (AI) and Machine Learning (ML) to revolutionize cancer care. It covers utilizing AI for rapid diagnostics, extracting prognostic features from complex imaging (Radiomics), personalizing treatment selection, and optimizing the efficiency of drug development pipelines.

• Machine Learning Applications
• Radiomics and Deep Learning for Image
• Prognosis Predictive Modeling
• Natural Language Processing (NLP)
• AI in Drug Discovery and Biomarker Identification
• Clinical Trial Optimization and Patient Matching
• Ethical Frameworks and Regulatory Challenges for Clinical AI